{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:14:19Z","timestamp":1792602859283,"version":"4.5.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8,6]]},"DOI":"10.1093\/jnci\/djn206","type":"journal-article","created":{"date-parts":[[2008,7,29]],"date-time":"2008-07-29T23:44:55Z","timestamp":1217375095000},"page":"1058-1067","source":"Crossref","is-referenced-by-count":147,"title":["New Insight Into Epirubicin Cardiac Toxicity: Competing Risks Analysis of 1097 Breast Cancer Patients"],"prefix":"10.1093","volume":"100","author":[{"given":"Marianne","family":"Ryberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorte","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitte","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben","family":"Skovsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Kragh","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,8,6]]},"reference":[{"issue":"2","key":"key\n\t\t\t\t20170520213948_bib1","first-page":"319","article-title":"Adriamycin (NSC-123 127) in breast cancer: an overview of studies","volume":"6","author":"Tormey","year":"1975","journal-title":"Cancer Chemother Rep"},{"issue":"5","key":"key\n\t\t\t\t20170520213948_bib2","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","article-title":"Risk factors for doxorubicin-induced congestive heart failure","volume":"91","author":"von Hoff","year":"1979","journal-title":"Ann Intern Med"},{"issue":"1","key":"key\n\t\t\t\t20170520213948_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF00176819","article-title":"The effectiveness of the anthracycline analogue 4\u2032-epidoxorubicin in the treatment of experimental tumours: a review","volume":"3","author":"Goldin","year":"1985","journal-title":"Invest New Drugs"},{"issue":"2","key":"key\n\t\t\t\t20170520213948_bib4","first-page":"261","article-title":"Phase II study of doxorubicin versus epirubicin in advanced breast cancer","volume":"70","author":"Brambilla","year":"1986","journal-title":"Cancer Treat Rev."},{"issue":"6","key":"key\n\t\t\t\t20170520213948_bib5","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1200\/JCO.1985.3.6.818","article-title":"A prospective randomised comparison of epirubicin and doxorubicin in advanced breast cancer","volume":"3","author":"Jain","year":"1985","journal-title":"J Clin Oncol"},{"issue":"11","key":"key\n\t\t\t\t20170520213948_bib6","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"issue":"11","key":"key\n\t\t\t\t20170520213948_bib7","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1200\/JCO.1998.16.11.3502","article-title":"Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer","volume":"16","author":"Ryberg","year":"1998","journal-title":"J Clin Oncol"},{"issue":"2","key":"key\n\t\t\t\t20170520213948_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1191\/0962280202sm281ra","article-title":"Competing risks as a multi-state model","volume":"11","author":"Andersen","year":"2002","journal-title":"Stat Methods Med Res."},{"issue":"6","key":"key\n\t\t\t\t20170520213948_bib9","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competitive risks: new representations of old estimates","volume":"8","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t20170520213948_bib10","first-page":"253","volume-title":"Diseases of the Heart and the Great Vessels. Nomenclature and Criteria for Diagnosis","author":"Criteria Committee of the New York Heart Association","year":"1994"},{"issue":"4","key":"key\n\t\t\t\t20170520213948_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/oxfordjournals.annonc.a057748","article-title":"Epirubicin and epirubicin and vindesine in advanced breast cancer. A phase III study","volume":"1","author":"Nielsen","year":"1996","journal-title":"Ann Oncol"},{"issue":"6","key":"key\n\t\t\t\t20170520213948_bib12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s002800000178","article-title":"Epirubicin or epirubicin and cisplatin as first-line therapy in advanced breast cancer","volume":"46","author":"Nielsen","year":"2000","journal-title":"Cancer Chemother Pharmacol"},{"issue":"11","key":"key\n\t\t\t\t20170520213948_bib13","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1200\/JCO.1990.8.11.1806","article-title":"Epirubicin cardiotocixity: a study of 135 patients with advanced breast cancer","volume":"8","author":"Nielsen","year":"1990","journal-title":"J Clin Oncol"},{"issue":"3","key":"key\n\t\t\t\t20170520213948_bib15","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1158\/0008-5472.CAN-06-3099","article-title":"Tamoxifen induces oxidative stress and mitochondrial apoptosis via stimulating mitochondrial nitric oxide synthase","volume":"67","author":"Nazarewicz","year":"2007","journal-title":"Cancer Res."},{"issue":"21","key":"key\n\t\t\t\t20170520213948_bib14","first-page":"5995","article-title":"Activation of caspase-3 and x-Jun NH2-terminal kinase-1 signalling pathways in tamoxifen-induced apoptosis of human breast cancer cells","volume":"60","author":"Mandlekar","year":"2001","journal-title":"Cancer Res."},{"issue":"39","key":"key\n\t\t\t\t20170520213948_bib16","doi-asserted-by":"crossref","first-page":"14495","DOI":"10.1073\/pnas.0601911103","article-title":"Activation of Rho-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays an essential role in cardiac myocyte apoptosis","volume":"103","author":"Chang","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"key\n\t\t\t\t20170520213948_bib17","first-page":"2747","article-title":"A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer","volume":"353","author":"The Breast International Group (BIG) 1-98 Collaborative group","year":"2005","journal-title":"N Engl J Med"},{"issue":"44","key":"key\n\t\t\t\t20170520213948_bib18","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2165\/00003088-200544110-00003","article-title":"Clinical pharmacokinetics of cyclophosphamide","volume":"11","author":"de Jonge","year":"2005","journal-title":"Clin Pharmacokinet"},{"issue":"93","key":"key\n\t\t\t\t20170520213948_bib19","first-page":"27","article-title":"Cardiotoxicity of 5-fluorouracil","volume":"3","author":"Tsibiri","year":"2006","journal-title":"Bull Cancer"},{"issue":"34","key":"key\n\t\t\t\t20170520213948_bib20","doi-asserted-by":"crossref","first-page":"8597","DOI":"10.1200\/JCO.2005.02.5841","article-title":"Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study","volume":"23","author":"Doyle","year":"2005","journal-title":"J Clin Oncol"},{"issue":"5","key":"key\n\t\t\t\t20170520213948_bib21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/djk064","article-title":"Long-term risk of cardiovascular disease in 10-years survivors of breast cancer","volume":"99","author":"Hooning","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"1-2","key":"key\n\t\t\t\t20170520213948_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11010-006-9144-4","article-title":"Insights into the role of DL-alfa-lipoic acid against cyclophosphamide induced alterations in calcium sensitivity of cardiac myofilaments","volume":"289","author":"Mythili","year":"2006","journal-title":"Mol Cell Biochem"},{"issue":"5","key":"key\n\t\t\t\t20170520213948_bib23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.etp.2007.06.006","article-title":"Increased glutathione levels and activity of PONI1 (phenyl acetate esterase) in the liver of rats after a single dose of cyclophosphamide: a defense mechanism?","volume":"59","author":"Abraham","year":"2007","journal-title":"Exp Toxicol Pathol"},{"issue":"6","key":"key\n\t\t\t\t20170520213948_bib24","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/01.ftd.0000177224.19294.92","article-title":"Population pharmacokinetics of cyclophosphamide and its metabolites 2-hydroxycyclophosphamide, 2-dechloroethylcyclophosphamide, and phosphamide mustard in high-dose combination with thiotepa and carboplatin","volume":"27","author":"de Jonge","year":"2005","journal-title":"Ther Drug Monit."},{"issue":"22","key":"key\n\t\t\t\t20170520213948_bib25","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1158\/1078-0432.CCR-07-1579","article-title":"Schisandrin B prevents doxorubicin-induced cardiotoxicity via enhancing gluthatione redox cycling","volume":"13","author":"Li","year":"2007","journal-title":"Clin Cancer Res."},{"issue":"9188","key":"key\n\t\t\t\t20170520213948_bib26","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(99)02245-X","article-title":"Morbidity and mortality of ischemic heart disease in high-risk breast-cancer patients after adjuvant post mastectomy systemic treatment with and without radiotherapy: analysis of DBCG 82b and 82c randomised trials","volume":"354","author":"Hojris","year":"1991","journal-title":"Lancet"},{"issue":"3","key":"key\n\t\t\t\t20170520213948_bib27","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1053-4296(03)00026-2","article-title":"Radiation-associated cardiovascular disease: manifestations and management","volume":"13","author":"Adams","year":"2003","journal-title":"Semin Oncol"},{"issue":"1","key":"key\n\t\t\t\t20170520213948_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0360-3016(00)00647-7","article-title":"The need for long-term surveillance for patient treated with curative radiotherapy for Hodgkin's disease: University of Minnesota experience","volume":"48","author":"Lee","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"12","key":"key\n\t\t\t\t20170520213948_bib29","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1200\/JCO.1991.9.12.2153","article-title":"Factors predicting for response, time to treatment failure, and survival in patients with metastastic breast cancer treated with DAVTH","volume":"9","author":"Falkson","year":"1991","journal-title":"J Clin Oncol"},{"issue":"12","key":"key\n\t\t\t\t20170520213948_bib30","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.1983.1.12.776","article-title":"Multivariate analysis of prognostic factors in metastatic breast cancer","volume":"1","author":"Hotobagyi","year":"1983","journal-title":"J Clin Oncol"},{"issue":"1","key":"key\n\t\t\t\t20170520213948_bib31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1008384019411","article-title":"Prognostic factors and long-term survival in 585 patients with metastatic breast cancer treated with epirubicin-based chemotherapy","volume":"12","author":"Ryberg","year":"2001","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t20170520213948_bib32","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1053\/j.seminoncol.2006.04.022","article-title":"Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer","volume":"33","author":"Jensen","year":"2006","journal-title":"Semin Oncol"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/100\/15\/1058\/17309838\/djn206.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T13:52:38Z","timestamp":1503496358000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/djn206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,6]]},"references-count":32,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2008,8,6]]},"published-print":{"date-parts":[[2008,8,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djn206","relation":{},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8,6]]}}}